15-Deoxy-Δ (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: Inhibition of NF-κB and MAP kinase pathways and suppression of cytokine and chemokine expression

Meng Liang Zhao, Celia F. Brosnan, Sunhee C. Lee

Research output: Contribution to journalArticle

16 Scopus citations


We studied the role of 15-deoxy-Δ (12,14)-PGJ2 (15d-PGJ2), a macrophage inhibitor with reported therapeutic effects on experimental allergic encephalomyelitis, in human astrocyte activation in vitro. 15d-PGJ2 inhibited a broad range of astrocyte inflammatory gene expression induced by IL-1, including cytokines (TNFα and IL-6), chemokines (RANTES/CCL5 and IP-10/CXCL10) and inducible nitric oxide synthase. 15d-PGJ2 inhibited transactivation of NF-κB-dependent promoters, as well as p38 and JNK MAPK phosphorylation induced by IL-1, while having no inhibitory effect on IFN-induced Stat signaling pathways. Our results demonstrating 15d-PGJ2-mediated astrocyte deactivation through inhibition of NF-κB are similar to those described for macrophages, and add astrocytes as additional targets for this prostaglandin (PG).

Original languageEnglish (US)
Pages (from-to)132-142
Number of pages11
JournalJournal of Neuroimmunology
Issue number1-2
Publication statusPublished - Aug 1 2004



  • Human
  • IL-8/CXCL8
  • IP-10/CXCL10
  • Inflammation
  • Prostaglandin

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this